Cargando…

Association Between Hormone-Modulating Breast Cancer Therapies and Incidence of Neurodegenerative Outcomes for Women With Breast Cancer

IMPORTANCE: The association between exposure to hormone-modulating therapy (HMT) as breast cancer treatment and neurodegenerative disease (NDD) is unclear. OBJECTIVE: To determine whether HMT exposure is associated with the risk of NDD in women with breast cancer. DESIGN, SETTING, AND PARTICIPANTS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Branigan, Gregory L., Soto, Maira, Neumayer, Leigh, Rodgers, Kathleen, Brinton, Roberta Diaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093781/ https://www.ncbi.nlm.nih.gov/pubmed/32207833 http://dx.doi.org/10.1001/jamanetworkopen.2020.1541

Ejemplares similares

Association between menopausal hormone therapy and risk of neurodegenerative diseases: Implications for precision hormone therapy
por: Kim, Yu Jin, et al.
Publicado: (2021)

Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer
por: Branigan, Gregory L., et al.
Publicado: (2022)

Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients
por: Torrandell-Haro, Georgina, et al.
Publicado: (2022)

Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
por: Torrandell‐Haro, Georgina, et al.
Publicado: (2020)

Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics
por: Branigan, Gregory L., et al.
Publicado: (2022)

Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers
por: Niraula, Saroj, et al.
Publicado: (2020)

Clinicopathological Characteristics and Breast Cancer–Specific Survival of Patients With Single Hormone Receptor–Positive Breast Cancer
por: Li, Yunhai, et al.
Publicado: (2020)

Breast cancer therapies reduce risk of Alzheimer’s disease and promote estrogenic pathways and action in brain
por: Branigan, Gregory L., et al.
Publicado: (2023)

Preventing Alzheimer's disease within reach by 2025: Targeted‐risk‐AD‐prevention (TRAP) strategy
por: Vitali, Francesca, et al.
Publicado: (2021)

Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden
por: Johansson, Annelie, et al.
Publicado: (2021)

Hormones and breast and endometrial cancers: preventive strategies and future research.
por: Hulka, B S, et al.
Publicado: (1995)

Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women
por: Trabert, Britton, et al.
Publicado: (2020)

Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer Before Starting Chemotherapy
por: Hu, Xin, et al.
Publicado: (2021)

Breast Cancer Incidence After a False-Positive Mammography Result
por: Mao, Xinhe, et al.
Publicado: (2023)

Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
por: Hu, Xin, et al.
Publicado: (2022)

Patient Perspectives on Treatment Options for Older Women With Hormone Receptor–Positive Breast Cancer: A Qualitative Study
por: Wang, Ton, et al.
Publicado: (2020)

Concomitant Discontinuation of Cardiovascular Therapy and Adjuvant Hormone Therapy Among Patients With Breast Cancer
por: He, Wei, et al.
Publicado: (2023)

Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France
por: Jabagi, Marie Joelle, et al.
Publicado: (2019)

Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women
por: Han, Yunan, et al.
Publicado: (2022)

Trends in Parity and Breast Cancer Incidence in US Women Younger Than 40 Years From 1935 to 2015
por: Lima, Sarah M., et al.
Publicado: (2020)

Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer
por: Shamai, Gil, et al.
Publicado: (2019)

Breast Cancer Hormone Therapy Modulates Breast Implant Capsular Contracture
por: Chawla, Mehak, et al.
Publicado: (2023)

Prolactin: The Third Hormone in Breast Cancer
por: Schuler, Linda A., et al.
Publicado: (2022)

Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer
por: Lønning, Per E., et al.
Publicado: (2022)

Socioeconomic status and incidence of breast cancer by hormone receptor subtype
por: Akinyemiju, Tomi F., et al.
Publicado: (2015)

Contraceptive Use in Premenopausal Women With Early Breast Cancer
por: Lambertini, Matteo, et al.
Publicado: (2022)

Hormonal content and potency of oral contraceptives and breast cancer risk among young women
por: Althuis, M D, et al.
Publicado: (2003)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer
por: Kim, Hakyoung, et al.
Publicado: (2023)

Epigenetic Regulation and Dietary Control of Triple Negative Breast Cancer
por: Selmin, Ornella I., et al.
Publicado: (2020)

Comparison of Mortality Among Participants of Women’s Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers
por: Irvin, Veronica L., et al.
Publicado: (2020)

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
por: Gallagher, Shannon, et al.
Publicado: (2020)

Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015
por: Kong, Xiangyi, et al.
Publicado: (2020)

Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016
por: Acheampong, Teofilia, et al.
Publicado: (2020)

Editorial: Hormones and receptors in breast cancer
por: Rosemblit, Cinthia, et al.
Publicado: (2023)

Assessment of Oncologists’ Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor–Positive Breast Cancer
por: Minami, Christina A., et al.
Publicado: (2022)

Prevalence of dermatological complaints in patients undergoing treatment for breast cancer
por: Hoffmann, Tamara, et al.
Publicado: (2018)

Breast Cancer Screening Among Women With Intellectual Disability in Denmark
por: Horsbøl, Trine Allerslev, et al.
Publicado: (2023)

Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden
por: Zhang, Yuqi, et al.
Publicado: (2023)

Breast weight and hormone receptor status in women with breast cancer
por: Salhab, M, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_edvpqckuit4vngbtv9af7dmhir